Literature DB >> 31264243

A variational approach to optimal two-stage designs.

Maximilian Pilz1, Kevin Kunzmann1, Carolin Herrmann2,3, Geraldine Rauch2,3, Meinhard Kieser1.   

Abstract

Recalculating the sample size in adaptive two-stage designs is a well-established method to gain flexibility in a clinical trial. Jennison and Turnbull (2015) proposed an "optimal" adaptive two-stage design based on the inverse normal combination test, which minimizes a mixed criterion of expected sample size under the alternative and conditional power. We demonstrate that the use of a combination test is not necessary to control the type one error rate and use variational techniques to develop a general adaptive design that is globally optimal under predefined optimality criteria. This approach yields to more efficient designs and furthermore allows to investigate the efficiency of the inverse normal method and the relation between local (interim-based) recalculation rules and global (unconditional) optimality of adaptive two-stage designs.
© 2019 John Wiley & Sons, Ltd.

Keywords:  adaptive design; clinical trial; inverse normal combination test; optimal design; sample size calculation

Mesh:

Year:  2019        PMID: 31264243     DOI: 10.1002/sim.8291

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials.

Authors:  Kevin Kunzmann; Michael J Grayling; Kim May Lee; David S Robertson; Kaspar Rufibach; James M S Wason
Journal:  Stat Med       Date:  2022-01-13       Impact factor: 2.497

2.  Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint.

Authors:  Xieran Li; Carolin Herrmann; Geraldine Rauch
Journal:  BMC Med Res Methodol       Date:  2020-11-05       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.